Literature DB >> 1686067

Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo.

J McCulloch1, L L Iversen.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1686067     DOI： 10.1007/bf00965838

Source DB:  PubMed          Journal:  Neurochem Res        ISSN： 0364-3190            Impact factor:   3.996


× No keyword cloud information.
  76 in total

1.  Quantitative autoradiographic localization of NMDA receptors in rat brain using [3H]CPP: comparison with [3H]TCP binding sites.

Authors:  M F Jarvis; D E Murphy; M Williams
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

Review 2.  Excitatory amino acid transmitters.

Authors:  J C Watkins; R H Evans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

3.  Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors.

Authors:  T S Rao; H S Kim; J Lehmann; L L Martin; P L Wood
Journal:  Neuropharmacology       Date:  1990-03       Impact factor: 5.250

4.  The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice.

Authors:  M Carlsson; A Svensson
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

5.  Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.

Authors:  W M Pardridge; D Triguero; J Yang; P A Cancilla
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

6.  Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

Authors:  R P Simon; J H Swan; T Griffiths; B S Meldrum
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

7.  Selection of experimental conditions for the accurate determination of blood--brain transfer constants from single-time experiments: a theoretical analysis.

Authors:  R G Blasberg; C S Patlak; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-06       Impact factor: 6.200

8.  The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.

Authors:  C K Park; D G Nehls; D I Graham; G M Teasdale; J McCulloch
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

9.  CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist.

Authors:  J Lehmann; A J Hutchison; S E McPherson; C Mondadori; M Schmutz; C M Sinton; C Tsai; D E Murphy; D J Steel; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1988-07       Impact factor: 4.030

10.  Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex.

Authors:  A Kurumaji; M Ikeda; D Dewar; A G McCormack; J McCulloch
Journal:  Brain Res       Date:  1991-11-01       Impact factor: 3.252
View more
  6 in total

1.  Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill; L L Iversen
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

2.  Augmentation of M-type (KCNQ) potassium channels as a novel strategy to reduce stroke-induced brain injury.

Authors:  Sonya M Bierbower; Frank S Choveau; James D Lechleiter; Mark S Shapiro
Journal:  J Neurosci       Date:  2015-02-04       Impact factor: 6.167

3.  Neuronal vacuole formation in the rat posterior cingulate/retrosplenial cortex after treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801 (dizocilpine maleate).

Authors:  A S Fix; J W Horn; L L Truex; R A Smith; E Gomez
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

4.  Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology.

Authors:  R J Hargreaves; M Rigby; D Smith; R G Hill
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

5.  The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801.

Authors:  R N Auer; K C Coulter
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 6.  Excitatory amino acid antagonists and their potential for the treatment of ischaemic brain damage in man.

Authors:  J McCulloch
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.